Ivan Pedrosa, M.D., Ph.D.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Stock Options
    Ineligible company:
    Health Tech International
    Topic:
    Telemedicine
    Date added:
    12/07/2021
    Date updated:
    05/01/2024
    Relationship end date:
    12/31/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Merck
    Topic:
    Advisory board
    Date added:
    12/07/2021
    Date updated:
    05/01/2024
    Relationship end date:
    03/04/2021
Return to 156 Renal Cell Carcinoma Multimodality Conference: (030722)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.